02/01/12 - Sophia-Antipolis, France

MEDIAN signe un contrat majeur avec Sanofi

MEDIAN Technologies signe un contrat majeur avec le laboratoire SANOFI pour l’interprétation et la gestion des images dans une nouvelle étude de phase II sur le cancer du poumon à petites cellules.

 
More info >  (413.2 Kb, PDF File)

02/01/12 - Sophia-Antipolis, France

MEDIAN has signed a landmark contract with Sanofi

MEDIAN Technologies has signed a landmark contract with the top pharmaceutical company SANOFI for medical image interpretation and management in a new phase II study on small cells lung cancer.

 
More info >  (408.8 Kb, PDF File)
 
/ Home
/ News

Press Releases

< Back to News List
MEDIAN Technologies Granted 1,5 Million Euros for Innovation Support from OSEO for the First Phase of LESIO Development
09/26/08 - Sophia Antipolis, France

Make possible an earlier cancer diagnosis and a better follow-up of patients affected by this disease, and contribute to optimal patient care, these are the ambitious objectives of MEDIAN Technologies with the development and the commercialization of its medical imaging applications for oncology.

MEDIAN Technologies, an innovative provider of advanced medical imaging interpretation solutions, has announced that OSEO Innovation granted the company with a financial help of 1,5 million euros to support the first phase of its development program in oncology imaging.

OSEO financial support will allow MEDIAN Technologies to accelerate the development and the launch on the market of a complete platform of oncology imaging, used for the assessment of cancer extension (evaluation and follow-up of cancerous or other suspicious lesions). This platform, LESIO, will allow the interpretation of combined imaging of molecular function and morphology.

Moreover, this platform will have the unique capability of being integrated in the different PACS (Picture Archiving and Communication System) workstations available on the market; LESIO will thus allow the use of advanced clinical applications for optimized therapeutic strategy by multi-disciplinary teams in all healthcare facilities

OSEO innovation has been supporting MEDIAN Technologies since its inception and renews its trust in the French Company financing this new ambitious and innovative project. MEDIAN Technologies took one big step forward in its ambition of becoming the world leader provider of oncology medical imaging applications.

"OSEO renews its support to MEDIAN Technologies with this new grant aimed at LESIO development. Its technological advances should allow the company to become a major player on this competitive and international market." Said Nadège TROGLIA, Account Manager Innovation.

About MEDIAN Technologies

MEDIAN Technologies develops and markets advanced clinical applications for diagnostic oncology imaging. The product range of the company, LMS - Lesion Management Solutions - is a set of clinical applications helping support of cancerous or suspect lesions diagnosed from scan images taken from the thoracic-abdominal-pelvic area. Today, the offer supply is structured around the 3 following leading products: LMS-Lung, LMS-Liver and LMS-Colon.